文献速递泌尿生殖MRUS

减少穿刺针数的新采样方案在多参数MRI可见病灶前列腺活检中的应用

Novel sampling scheme with reduced cores in men with multiparametric MRI-visible lesions undergoing prostate biopsy.
PubMed 文献 · Abdom Radiol (NY) · 2023-04-10

本研究纳入464例MRI可见病灶(PI-RADS≥3)患者,均行靶向穿刺(TB)和系统穿刺(SB),比较多种减少穿刺针数方案的临床显著前列腺癌(csPCa)检出率。结果显示TB+同侧SB仅漏诊0.3%的csPCa,可能为最优方案;多病灶亚组中非索引病灶活检病理信息有限。

要点

  • TB+同侧SB方案漏诊csPCa仅0.3%,显著优于TB单独穿刺。
  • TB+对侧SB与TB单独穿刺相比csPCa检出率无显著差异(p=0.063)。
  • 多病灶患者中非索引病灶未显示比索引病灶更高的Gleason分级。
英文原文(摘要)· 点击展开

PURPOSE: To investigate the effects of various prostate biopsy protocols with reduced cores on the detection of clinically significant prostate cancer (csPCa) in individuals with MRI-visible lesions (Prostate Imaging Reporting and Data System ≥ 3).

METHODS: A total of 464 patients with MRI-visible lesions were recruited. All patients underwent two or more targeted biopsies (TB) and systematic biopsies (SB). Several hypothetical biopsy schemes were set-up: TB alone, TB+ipsilateral SB, TB+contralateral SB, TB+SB of the targeted sector (TB+t-SB), and TB+SB of the non-targeted sector (TB+n-SB). A subgroup analysis of patients with multiple MRI-visible lesions was performed. The standard of reference was defined as TB+SB. McNemar test was used to compare csPCa detection rates between various sampling schemes.

RESULTS: The detection rates for prostate cancer and csPCa were 72.8% (338 of 464) and 62.1% (288 of 464), respectively. There were 8.0%, 0.3%, 6.3%, 1.0%, and 4.5% cases in which TB alone, TB+ipsilateral SB, TB+contralateral SB, TB+t-SB, and TB+n-SB would have missed csPCa, respectively. All hypothetical schemes, with the exception of TB+contralateral SB (p = 0.063), significantly outperformed TB alone in terms of csPCa detection (p < 0.05). As for the multi-focus cohort, which included 48 cases, none of the non-index lesions had a higher Gleason grade than the index lesions within the same patients.

CONCLUSION: TB+ipsilateral SB might be the optimal biopsy scheme for detecting csPCa. As for the multi-focus cohort, the biopsy of the non-index lesions provided limited pathological information.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Ruan, Wang, Li, et al. Novel sampling scheme with reduced cores in men with multiparametric MRI-visible lesions undergoing prostate biopsy. Abdom Radiol (NY). 2023. PMID: 37036488. doi:10.1007/s00261-023-03894-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。